Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
With the growing use of computed tomography (CT) scans, there has been a corresponding increase in detection of incidental adrenal lesions. For decades, tumor size has been associated with malignancy, however emerging research has suggested that the majority of large (> 4 cm) adrenal lesions are benign and do not require surgical resection. With CT being the gold-standard imaging modality for evaluating adrenal lesions, it is important to differentiate benign and malignant lesions on imaging to guide clinical management and avoid overtreatment. In this first part of the pictorial essay, we discuss the CT appearances of benign adrenal lesions including adenoma, cyst, myelolipoma, lymphangioma, and neurogenic tumors, to effectively differentiate them from malignant lesions. Malignant adrenal tumors, as well as pheochromocytoma, which is commonly benign but can rarely be malignant, are discussed in detail in part 2 of the paper.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00261-025-05177-3 | DOI Listing |